Uncertain Optimism: The Healthcare Outlook from HPE Miami

Uncertain Optimism: The Healthcare Outlook from HPE Miami

Earlier this month, more than 2,200 healthcare leaders convened for McDermott Will & Emery’s Healthcare Private Equity (HPE) Miami conference to discuss the evolving challenges and trends shaping the healthcare industry in 2025. For two days in the Miami sun, attendees were able to engage with insightful panels that covered topics ranging from how to navigate private equity investments to what the hot investment sectors are. A plethora of topics were explored by panelists and perspectives, and although opinions varied on the trajectory of M&A activity in 2025, a prevailing sentiment of cautious optimism emerged… if investors play their cards right. Several themes stuck out to the... Read More »
Healthcare M&A Cools: February 2025 Signals a Slow Year Ahead

Healthcare M&A Cools: February 2025 Signals a Slow Year Ahead

If healthcare M&A activity of February 2025 is any indication for how the rest of the year will play out, 2025 may not be a year of strong activity. According to data captured in the LevinPro HC database, throughout the month, there were 114 healthcare transactions reported. This is a 49% decrease from the 223 announced in January 2025 and a 17% decline from the 138 reported in February 2024. The most active sector was the Other Services sector with 30 transactions. This is not surprising considering Other Services encompasses medical outpatient buildings (MOBs), which has seen notable demand over the past few years. In February 2024, 37 transactions were reported, and in January 2025,... Read More »
Economic and Election Uncertainty Slows 2024 Physician Group M&A Activity

Economic and Election Uncertainty Slows 2024 Physician Group M&A Activity

The Physician Medical Group (PMG) sector experienced a decline in deal volume throughout the year. In 2024, 473 PMG deals were announced, a 12% decline from the 537 PMG deals announced in 2023 and a 24% decrease from the 622 deals reported in 2022. In the fourth quarter of 2024, there were 101 PMG deals, which is the slowest quarter for the year.  Some advisors that the LevinPro HC team has spoken to throughout the year have noted several significant factors contributing to the decline in PMG deal volume. Common themes that advisors cited were uncertainty surrounding the election, an unstable economy, higher interest rates and even heightened scrutiny surrounding private equity... Read More »
The Current State of the Healthcare Investment Market: Insights from the McGuireWoods Healthcare Finance and Growth Conference

The Current State of the Healthcare Investment Market: Insights from the McGuireWoods Healthcare Finance and Growth Conference

McGuireWoods’ 17th Annual Healthcare Finance and Growth Conference brought together more than 200 healthcare leaders to explore the latest developments and challenges shaping the industry in 2024 and beyond. Through a combination of in-depth panels and engaging networking sessions, attendees had the opportunity to connect with industry peers and gain insights into emerging trends and sectors, from the future of telehealth to the evolving role of value-based care in driving healthcare outcomes. With 15 panels and 57 speakers, the conference covered a wide array of topics, offering actionable strategies for navigating the current and evolving healthcare investment market landscape. On day... Read More »
Healthcare M&A Dips: August Sees 9% Decline in Deals

Healthcare M&A Dips: August Sees 9% Decline in Deals

Healthcare mergers & acquisitions (M&A) deal activity declined in August 2024, according to data captured in the LevinPro HC database. Totaling 161 transactions throughout the month, this is an approximately 9% decrease from July 2024, when 177 healthcare transactions were reported. The deal volume of the entirety of August 2024 accounts for nearly 12% of the 1,352 healthcare transactions announced since the start of the year.  While most sectors reported similar numbers between July and August, markets such as Other Services and Biotechnology & Pharmaceuticals (Biopharma) saw a steep decline. The Biopharma space declined from 18 transactions in July 2024 to 14 in August... Read More »
Most Active States for Healthcare Services M&A in 2024 (So Far)

Most Active States for Healthcare Services M&A in 2024 (So Far)

As the healthcare industry continues to evolve, mergers and acquisitions (M&As) have become a strategic tool for providers to expand their reach, enhance services and improve efficiency. This year, certain states have emerged as particularly active hubs for healthcare services M&A. The healthcare services sectors included in this report include Behavioral Health Care, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Physician Medical Groups, Rehabilitation and Other Services (a mix of companies providing ancillary healthcare services, or those relating to healthcare). This analysis examines the most active U.S. states and regions... Read More »